menu search

Wave life sciences third quarter 2023 financial results scheduled for november 9, 2023

CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA ...

November 3, 2023, 8:05 pm

Cliff notes: a central bank trifecta

Key insights from the week that was. In Australia, nominal retail sales rose strongly in September, up 0.9% (2.0%yr). However, this was mostly due to ...

November 3, 2023, 5:22 am

Kura oncology and mirati therapeutics enter into clinical collaboration and supply agreement to evaluate ko-2806 and adagrasib in krasᴳ¹²ᶜ-mutated nsclc

– Ongoing Phase 1 dose-escalation trial of KO-2806 (FIT-001) expected to begin dosing patients in combination with adagrasib by mid-2024 – SAN DIE...

November 2, 2023, 11:30 am

Mckesson lifts annual profit forecast after strong quarterly results

Drug distributor McKesson Corp on Wednesday raised its annual profit forecast, banking on strong demand for specialty medicines....

November 1, 2023, 6:27 pm

Gsk beats on q3 earnings and sales, raises 2023 guidance

GSK's revenues benefit from strong growth across the Specialty medicines and Vaccines segments. The com...

November 1, 2023, 12:47 pm

Springworks therapeutics announces presentation of additional data from phase 3 defi trial of nirogacestat in adults with desmoid tumors at the 2023 ctos annual meeting

– Nirogacestat Treatment Demonstrated Rapid and Sustained Improvements in Functional Status Compared to Placebo Across Multiple Assessment Tools –...

November 1, 2023, 10:30 am

Uk regulator approves pfizer's hair loss drug

Britain's medicines regulator on Wednesday approved Pfizer Inc's drug to treat hair loss caused by an a...

November 1, 2023, 7:39 am

Revolution medicines to report financial results for third quarter 2023 after market close on november 6, 2023

REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel ...

October 31, 2023, 4:15 pm

Crsp stock halt: crispr trading halted ahead of fda decision

Among the more prominent gene-editing stocks on the market, investors in this space pay particularly close attention to CRISPR Therapeutics (NASDAQ: C...

October 31, 2023, 2:11 pm

Are medical stocks lagging biohaven ltd. (bhvn) this year?

Here is how Biohaven Ltd. (BHVN) and Blueprint medicines (BPMC) have performed compared to their sector...

October 31, 2023, 11:21 am

Bioxcel therapeutics to report third quarter 2023 financial results on november 14, 2023

NEW HAVEN, Conn., Oct. 31, 2023 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intel...

October 31, 2023, 11:00 am

Merck just made a big move -- but will it be enough for investors right now?

Merck and Daiichi Sankyo just signed a multibillion-dollar drug collaboration. The pair will work to develop three ...

October 31, 2023, 10:15 am

Verve and lilly relationship expands to include verve’s in vivo gene editing programs targeting pcsk9 and angptl3

Lilly Purchases Product Rights to Verve’s Lead Cardiovascular Programs from Beam Therapeutics BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) — Verve Thera...

October 31, 2023, 10:01 am

Kura oncology to participate in three upcoming investor conferences

SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the...

October 30, 2023, 7:30 am

Sanofi (sny) q3 2023 earnings call transcript

Sanofi (NASDAQ:SNY ) Q3 2023 Earnings Conference Call October 27, 2023 9:00 AM ET Company Participants Eva Schaefer-Jansen - Head of Investor Relation...

October 27, 2023, 2:26 pm

Monte rosa therapeutics announces $25 million registered direct offering, priced at- the-market under nasdaq rules

BOSTON, Oct. 26, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molec...

October 26, 2023, 8:30 pm

Why blueprint medicines stock soared today

Blueprint medicines delivered an exceptional quarter with a positive reception for Ayvakit in its first...

October 26, 2023, 5:47 pm

Blueprint medicines (bpmc) reports q3 loss, tops revenue estimates

Blueprint medicines (BPMC) came out with a quarterly loss of $2.20 per share versus the Zacks Consensus...

October 26, 2023, 9:48 am

Why is lianbio (lian) stock up 130% today?

Shares of LianBio (NASDAQ: LIAN ) — which focuses on “developing and commercializing medicines for ...

October 24, 2023, 1:48 pm

Novartis raises outlook after sandoz generics spinoff

Novartis CEO Vas Narasimhan discusses third-quarter results with the company lifting its profit forecast for a third time as he calls the drugmaker a ...

October 24, 2023, 6:24 am


Search within

Pages Search Results: